C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathways

Yoshihiro Maeda, Yoshiaki Kawano, Yoshihiro Wada, Junji Yatsuda, Takanobu Motoshima, Yoji Murakami, Ken Kikuchi, Takahisa Imamura, Masatoshi Eto

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The anaphylatoxin C5a is a chemoattractant for leukocyte migration via the C5a receptor (C5aR). We recently reported that C5aR was aberrantly expressed in a wide variety of human related cancers, while it also promotes cancer cell invasion by C5a stimulation. However, the biological signifi- cance of C5aR expression in renal cell carcinoma (RCC) has not yet been clarified. In the present study, we aimed to elucidate the biological role of C5aR in RCC progression. Clinical RCC specimens were analyzed for C5aR expression and its relationship with baseline demographic data and clinicopathological parameters was analyzed. Moreover, renal carcinoma Renca cells stably expressing C5aR were generated and used to assess the effects of C5a-C5aR axis activation on various cellular phenomena in culture. Immunohistochemistry revealed that 96.7% of the metastatic RCCs (mRCCs) showed C5aR expression, whereas only 50.5% of the non-metastatic RCCs expressed C5aR (P<0.001). Although C5a stimulation did not significantly alter anoikis of C5aR-expressing Renca cells, C5a elicited cell morphological change and scattering of those cells accompanied with dynamic actin rearrangement, which was not observed in the Renca cells harboring the empty vector only. Moreover, C5a triggered ERK and PI3K-dependent invasion of the C5aR-expressing renal carcinoma cells. These results are consistent with the idea that the C5a-C5aR axis plays a crucial role in renal carcinoma cell invasion, which may be one of the key steps for RCC metastasis. The present study provides proof-of-concept that the C5a-C5aR axis may be a useful therapeutic target for preventing RCC progression.

Original languageEnglish
Pages (from-to)1844-1850
Number of pages7
JournalOncology Reports
Volume33
Issue number4
DOIs
Publication statusPublished - Apr 1 2015
Externally publishedYes

Fingerprint

Anaphylatoxin C5a Receptor
Phosphatidylinositol 3-Kinases
Renal Cell Carcinoma
Anoikis
Anaphylatoxins
Chemotactic Factors

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathways. / Maeda, Yoshihiro; Kawano, Yoshiaki; Wada, Yoshihiro; Yatsuda, Junji; Motoshima, Takanobu; Murakami, Yoji; Kikuchi, Ken; Imamura, Takahisa; Eto, Masatoshi.

In: Oncology Reports, Vol. 33, No. 4, 01.04.2015, p. 1844-1850.

Research output: Contribution to journalArticle

Maeda, Y, Kawano, Y, Wada, Y, Yatsuda, J, Motoshima, T, Murakami, Y, Kikuchi, K, Imamura, T & Eto, M 2015, 'C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathways', Oncology Reports, vol. 33, no. 4, pp. 1844-1850. https://doi.org/10.3892/or.2015.3800
Maeda, Yoshihiro ; Kawano, Yoshiaki ; Wada, Yoshihiro ; Yatsuda, Junji ; Motoshima, Takanobu ; Murakami, Yoji ; Kikuchi, Ken ; Imamura, Takahisa ; Eto, Masatoshi. / C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathways. In: Oncology Reports. 2015 ; Vol. 33, No. 4. pp. 1844-1850.
@article{ee66235d50d6482f87d834ce3195423a,
title = "C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathways",
abstract = "The anaphylatoxin C5a is a chemoattractant for leukocyte migration via the C5a receptor (C5aR). We recently reported that C5aR was aberrantly expressed in a wide variety of human related cancers, while it also promotes cancer cell invasion by C5a stimulation. However, the biological signifi- cance of C5aR expression in renal cell carcinoma (RCC) has not yet been clarified. In the present study, we aimed to elucidate the biological role of C5aR in RCC progression. Clinical RCC specimens were analyzed for C5aR expression and its relationship with baseline demographic data and clinicopathological parameters was analyzed. Moreover, renal carcinoma Renca cells stably expressing C5aR were generated and used to assess the effects of C5a-C5aR axis activation on various cellular phenomena in culture. Immunohistochemistry revealed that 96.7{\%} of the metastatic RCCs (mRCCs) showed C5aR expression, whereas only 50.5{\%} of the non-metastatic RCCs expressed C5aR (P<0.001). Although C5a stimulation did not significantly alter anoikis of C5aR-expressing Renca cells, C5a elicited cell morphological change and scattering of those cells accompanied with dynamic actin rearrangement, which was not observed in the Renca cells harboring the empty vector only. Moreover, C5a triggered ERK and PI3K-dependent invasion of the C5aR-expressing renal carcinoma cells. These results are consistent with the idea that the C5a-C5aR axis plays a crucial role in renal carcinoma cell invasion, which may be one of the key steps for RCC metastasis. The present study provides proof-of-concept that the C5a-C5aR axis may be a useful therapeutic target for preventing RCC progression.",
author = "Yoshihiro Maeda and Yoshiaki Kawano and Yoshihiro Wada and Junji Yatsuda and Takanobu Motoshima and Yoji Murakami and Ken Kikuchi and Takahisa Imamura and Masatoshi Eto",
year = "2015",
month = "4",
day = "1",
doi = "10.3892/or.2015.3800",
language = "English",
volume = "33",
pages = "1844--1850",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "4",

}

TY - JOUR

T1 - C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathways

AU - Maeda, Yoshihiro

AU - Kawano, Yoshiaki

AU - Wada, Yoshihiro

AU - Yatsuda, Junji

AU - Motoshima, Takanobu

AU - Murakami, Yoji

AU - Kikuchi, Ken

AU - Imamura, Takahisa

AU - Eto, Masatoshi

PY - 2015/4/1

Y1 - 2015/4/1

N2 - The anaphylatoxin C5a is a chemoattractant for leukocyte migration via the C5a receptor (C5aR). We recently reported that C5aR was aberrantly expressed in a wide variety of human related cancers, while it also promotes cancer cell invasion by C5a stimulation. However, the biological signifi- cance of C5aR expression in renal cell carcinoma (RCC) has not yet been clarified. In the present study, we aimed to elucidate the biological role of C5aR in RCC progression. Clinical RCC specimens were analyzed for C5aR expression and its relationship with baseline demographic data and clinicopathological parameters was analyzed. Moreover, renal carcinoma Renca cells stably expressing C5aR were generated and used to assess the effects of C5a-C5aR axis activation on various cellular phenomena in culture. Immunohistochemistry revealed that 96.7% of the metastatic RCCs (mRCCs) showed C5aR expression, whereas only 50.5% of the non-metastatic RCCs expressed C5aR (P<0.001). Although C5a stimulation did not significantly alter anoikis of C5aR-expressing Renca cells, C5a elicited cell morphological change and scattering of those cells accompanied with dynamic actin rearrangement, which was not observed in the Renca cells harboring the empty vector only. Moreover, C5a triggered ERK and PI3K-dependent invasion of the C5aR-expressing renal carcinoma cells. These results are consistent with the idea that the C5a-C5aR axis plays a crucial role in renal carcinoma cell invasion, which may be one of the key steps for RCC metastasis. The present study provides proof-of-concept that the C5a-C5aR axis may be a useful therapeutic target for preventing RCC progression.

AB - The anaphylatoxin C5a is a chemoattractant for leukocyte migration via the C5a receptor (C5aR). We recently reported that C5aR was aberrantly expressed in a wide variety of human related cancers, while it also promotes cancer cell invasion by C5a stimulation. However, the biological signifi- cance of C5aR expression in renal cell carcinoma (RCC) has not yet been clarified. In the present study, we aimed to elucidate the biological role of C5aR in RCC progression. Clinical RCC specimens were analyzed for C5aR expression and its relationship with baseline demographic data and clinicopathological parameters was analyzed. Moreover, renal carcinoma Renca cells stably expressing C5aR were generated and used to assess the effects of C5a-C5aR axis activation on various cellular phenomena in culture. Immunohistochemistry revealed that 96.7% of the metastatic RCCs (mRCCs) showed C5aR expression, whereas only 50.5% of the non-metastatic RCCs expressed C5aR (P<0.001). Although C5a stimulation did not significantly alter anoikis of C5aR-expressing Renca cells, C5a elicited cell morphological change and scattering of those cells accompanied with dynamic actin rearrangement, which was not observed in the Renca cells harboring the empty vector only. Moreover, C5a triggered ERK and PI3K-dependent invasion of the C5aR-expressing renal carcinoma cells. These results are consistent with the idea that the C5a-C5aR axis plays a crucial role in renal carcinoma cell invasion, which may be one of the key steps for RCC metastasis. The present study provides proof-of-concept that the C5a-C5aR axis may be a useful therapeutic target for preventing RCC progression.

UR - http://www.scopus.com/inward/record.url?scp=84924874096&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924874096&partnerID=8YFLogxK

U2 - 10.3892/or.2015.3800

DO - 10.3892/or.2015.3800

M3 - Article

VL - 33

SP - 1844

EP - 1850

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 4

ER -